Psomagen has announced the expansion of its single-cell capabilities by integrating the LevitasBio LeviCell EOS system into its service. This cutting-edge technology is a solution of choice to enhance the gentle purification process before single-cell sequencing, supporting clients’ needs for consistent, high-quality data. Alongside this, Psomagen has also incorporated Parse Biosciences into its single-cell portfolio, […]

LOS ANGELES — Partillion Bioscience Corporation (“Partillion”), a life science tools company, announced the launch of its Early Access Program for the Nanovial Multicell Assays. This innovative platform is designed to transform the study of cell-to-cell interactions by allowing researchers to co-localize cells within Nanovials, hydrogel nanoliter compartments, offering unprecedented insights into cellular behavior in […]

Certification Emphasizes Unwavering Commitment to Quality and Is an Essential Step for U.S. Clinical Market Entry FREMONT, Calif. — Today Cytek Biosciences, Inc. (Nasdaq: CTKB) announced that its San Diego reagent manufacturing facility has been awarded EN ISO 13485:2016 Quality Management System (QMS) certification. This certification encompasses the design, development, manufacturing, and distribution of reagents and […]

Combined expertise in primary cell and exosome isolation, skin products and services will advance global research  BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, has acquired ZenBio Inc., a distinguished industry leader in advanced cell products and services. Together, BioIVT and ZenBio will offer an expanded portfolio of skin-based […]

HERCULES, Calif. —  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Jon DiVincenzo will join the company as President and Chief Operating Officer, effective September 9, 2024, replacing Andy Last, who is retiring. Mr. DiVincenzo joins Bio-Rad from Labcorp Holdings Inc., a […]

Zurich, Switzerland, Brussels, Belgium, and New York, US — InSphero, a leading innovator in 3D Cell Culture and Organ-on-Chip technology, has announced a new collaboration with Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, and the Université Libre de Bruxelles (ULB) Center for Diabetes Research. With funding from Breakthrough T1D under its Industry Discovery & […]

Phase Holographic Imaging (PHI) is thrilled to announce its official approval for listing on the OTCQB Venture Market in the U.S., with trading commencing yesterday, Thursday, August 15th. This marks an important milestone in expanding our reach and enhancing accessibility for U.S. investors, setting the stage for improved engagement and continued growth. Effective August 15th, […]

NEWARK, Calif. — ATUM, a leading US-based provider of integrated biologics solutions, proudly announces the launch of the CHO-K1-derived discoCHO™ cell line for transient protein production. ATUM’s discoCHO enables robust transient therapeutic protein expression displaying critical quality attributes similar to those of the stable CHO-K1 manufacturing cell line miCHO-GS. CHO-K1 cells are the dominant cell line used […]

The collaboration focuses on offering guidance, mentorship, and access to expertise to the start-ups housed within NSG Biolabs SINGAPORE, — NSG BioLabs, Singapore’s largest provider of biotech co-working laboratory and office space, and the Life Science business of Merck Singapore, announce partnership giving biotech start-ups access to resources and expertise to bolster the research and […]

UPPSALA, Sweden — MAGic BioProcessing is pleased to announce the appointment of Günter Jagschies new board member while also acknowledging the departure of our valued board member Kristina Köhler. These changes mark an important step in the company’s ongoing commitment to excellence and strategic growth. Dr. Jagschies brings a wealth of experience and expertise in the bioprocessing […]